Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Director | Common Stock | 3.5K | $933K | $266.45 | Aug 6, 2024 | by Trust |
ALNYLAM PHARMACEUTICALS, INC. | Director | Common Stock | 136 | $36.2K | $266.45 | Aug 6, 2024 | Direct |
Seres Therapeutics, Inc. | Director | Stock Option (right to buy) | 64.6K | Jul 1, 2024 | Direct | ||
Rani Therapeutics Holdings, Inc. | Director | Stock Option (Right to Buy) | 50K | May 29, 2024 | Direct | ||
ALNYLAM PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 0 | Aug 6, 2024 | Direct |